114 related articles for article (PubMed ID: 34884657)
1. The investigation of cytotoxic and apoptotic activity of Cl-amidine on the human U-87 MG glioma cell line.
Öğüten PN; Engür Öztürk S; Dikmen M
Medicine (Baltimore); 2024 Feb; 103(8):e37015. PubMed ID: 38394536
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of PAD4-mediated NET formation by cl-amidine prevents diabetes development in nonobese diabetic mice.
Shen Y; You Q; Wu Y; Wu J
Eur J Pharmacol; 2022 Feb; 916():174623. PubMed ID: 34767782
[TBL] [Abstract][Full Text] [Related]
3. Peptidylarginine Deiminases Inhibitors Decrease Endothelial Cells Angiogenic Potential by Affecting Akt Signaling and the Expression and Secretion of Angiogenic Factors.
Ciesielski O; Pirola L; Balcerczyk A
Cell Physiol Biochem; 2024 Feb; 58(1):63-82. PubMed ID: 38374715
[TBL] [Abstract][Full Text] [Related]
4. Abrogation of collagen-induced arthritis by a peptidyl arginine deiminase inhibitor is associated with modulation of T cell-mediated immune responses.
Kawalkowska J; Quirke AM; Ghari F; Davis S; Subramanian V; Thompson PR; Williams RO; Fischer R; La Thangue NB; Venables PJ
Sci Rep; 2016 May; 6():26430. PubMed ID: 27210478
[TBL] [Abstract][Full Text] [Related]
5. Peptidyl arginine deiminase inhibition alleviates angiotensin II-induced fibrosis.
Ijichi T; Sundararaman N; Martin TG; Pandey R; Koronyo E; Kirk JA; Marbán E; Van Eyk JE; Fert-Bober J
Am J Transl Res; 2023; 15(7):4558-4572. PubMed ID: 37560217
[TBL] [Abstract][Full Text] [Related]
6. Localized Delivery of Cl-Amidine From Electrospun Polydioxanone Templates to Regulate Acute Neutrophil NETosis: A Preliminary Evaluation of the PAD4 Inhibitor for Tissue Engineering.
Fetz AE; Neeli I; Buddington KK; Read RW; Smeltzer MP; Radic MZ; Bowlin GL
Front Pharmacol; 2018; 9():289. PubMed ID: 29643810
[TBL] [Abstract][Full Text] [Related]
7. On the bioprotective effects of 3-hydroxybutyrate: Thermodynamic study of binary 3HB-water systems.
Slaninova E; Obruca S; Kocherbitov V; Sedlacek P
Biophys J; 2023 Feb; 122(3):460-469. PubMed ID: 36617191
[TBL] [Abstract][Full Text] [Related]
8. Effect of Peptidylarginine Deiminase 4 on Endothelial Progenitor Cell Function in Peripheral Arterial Disease.
Pan J; Liu W; Chen Y; Zhang C; Lin C
Evid Based Complement Alternat Med; 2021; 2021():7550693. PubMed ID: 34349829
[TBL] [Abstract][Full Text] [Related]
9. Role and Therapeutic Targeting Strategies of Neutrophil Extracellular Traps in Inflammation.
Li X; Xiao S; Filipczak N; Yalamarty SSK; Shang H; Zhang J; Zheng Q
Int J Nanomedicine; 2023; 18():5265-5287. PubMed ID: 37746050
[TBL] [Abstract][Full Text] [Related]
10. Peptidylarginine Deiminases-Roles in Cancer and Neurodegeneration and Possible Avenues for Therapeutic Intervention via Modulation of Exosome and Microvesicle (EMV) Release?
Lange S; Gallagher M; Kholia S; Kosgodage US; Hristova M; Hardy J; Inal JM
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587234
[TBL] [Abstract][Full Text] [Related]
11. Physiology, regulation, and limits of the synthesis of poly(3HB).
Babel W; Ackermann JU; Breuer U
Adv Biochem Eng Biotechnol; 2001; 71():125-57. PubMed ID: 11217410
[TBL] [Abstract][Full Text] [Related]
12. Controlled Delivery of Pan-PAD-Inhibitor Cl-Amidine Using Poly(3-Hydroxybutyrate) Microspheres.
Ahmed D; Puthussery H; Basnett P; Knowles JC; Lange S; Roy I
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884657
[TBL] [Abstract][Full Text] [Related]
13. Controlled delivery of gentamicin using poly(3-hydroxybutyrate) microspheres.
Francis L; Meng D; Knowles J; Keshavarz T; Boccaccini AR; Roy I
Int J Mol Sci; 2011; 12(7):4294-314. PubMed ID: 21845079
[TBL] [Abstract][Full Text] [Related]
14. Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor.
Chumanevich AA; Causey CP; Knuckley BA; Jones JE; Poudyal D; Chumanevich AP; Davis T; Matesic LE; Thompson PR; Hofseth LJ
Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G929-38. PubMed ID: 21415415
[TBL] [Abstract][Full Text] [Related]
15. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
